Russell Pachynski

19PUBLICATIONS
234CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisMolecular targetsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 10, 2026
Automating neoantigen selection for personalized cancer vaccine design.

|May 07, 2026
Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial.

|Apr 24, 2026
Phase 2 trial of pTVG-HP ± pTVG-AR DNA vaccines and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC).

|Apr 17, 2026
Spatial Mapping of the Precancer-to-Cancer Transition in Breast and Prostate.

|Apr 17, 2026
AR and Beyond: ctDNA Maps Resistance Evolution in mCRPC.

|Dec 08, 2025
Synergistic potential of sipuleucel-T in enhancing immunotherapy for metastatic castration-resistant prostate cancer.

Kavita Rawat, Varnika Punia, Parker Mathews

Pageof 4

Frequent Collaborators

3 joint publications

Melissa A Reimers

2 joint publications

Aadel A Chaudhuri

2 joint publications

Daniel P Petrylak

2 joint publications

Pradeep S Chauhan